{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:58:29Z","timestamp":1791381509028,"version":"4.3.3"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["1SC1AI096108-01A2"],"award-info":[{"award-number":["1SC1AI096108-01A2"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.exppara.2015.11.002","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T12:30:09Z","timestamp":1448541009000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica"],"prefix":"10.1016","volume":"160","author":[{"given":"Francheska","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Espino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2015.11.002_bib1","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0264-410X(99)00572-1","article-title":"Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration","volume":"18","author":"Baldridge","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib2","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1128\/IAI.67.10.5372-5378.1999","article-title":"Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis","volume":"67","author":"Brady","year":"1999","journal-title":"Inf. Immunol."},{"key":"10.1016\/j.exppara.2015.11.002_bib3","first-page":"400","article-title":"A\u00a0retrospective review of lesions associated with the use of Freund's adjuvant. Lab","volume":"39","author":"Broderson","year":"1989","journal-title":"Anim. Sci."},{"key":"10.1016\/j.exppara.2015.11.002_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/BJ20050051","article-title":"A\u00a0short guided tour through functional and structural features of saposin-like proteins","volume":"389","author":"Bruhn","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.exppara.2015.11.002_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.actatropica.2013.08.012","article-title":"Differential expression and localization of saposin-like protein 2 of Fasciola hepatica","volume":"128","author":"Caban-Hernandez","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2015.11.002_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1645\/0022-3395(2001)087[0697:IAFHIR]2.0.CO;2","article-title":"Immunoprophylaxis against Fasciola hepatica in rabbits using a recombinant Fh15 fatty acid-binding protein","volume":"87","author":"Casanueva","year":"2001","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.exppara.2013.06.010","article-title":"Vaccine potential of recombinant cathepsin B against Fasciola gigantica","volume":"135","author":"Chantree","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib8","doi-asserted-by":"crossref","first-page":"17038","DOI":"10.1074\/jbc.M308831200","article-title":"Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propetide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells","volume":"279","author":"Collins","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.exppara.2015.11.002_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/intimm\/dxg049","article-title":"Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid","volume":"15","author":"Cribbs","year":"2003","journal-title":"Int. Immunol."},{"key":"10.1016\/j.exppara.2015.11.002_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s004360050116","article-title":"Parasite vaccine development: large-scale recovery of immunogenic Taenia ovis fusion protein GST-45W(B\/X) from Escherichia coli inclusion bodies","volume":"82","author":"Dempster","year":"1996","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2015.11.002_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1128\/IAI.73.1.166-173.2005","article-title":"Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages","volume":"73","author":"Donnelly","year":"2005","journal-title":"Inf. Immunol."},{"key":"10.1016\/j.exppara.2015.11.002_bib12","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1096\/fj.08-106278","article-title":"Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages","volume":"22","author":"Donnelly","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.exppara.2015.11.002_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1645\/GE-3113","article-title":"Molecular cloning of a member of the Fasciola hepatica saposin-like protein family","volume":"89","author":"Espino","year":"2003","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1645\/GE-215R","article-title":"A\u00a0novel Fasciola hepatica saposin-like recombinant protein with immunoprophylactic potential","volume":"90","author":"Espino","year":"2004","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib15","article-title":"Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct","volume":"20","author":"Espino","year":"2010","journal-title":"Ethn. Dis."},{"key":"10.1016\/j.exppara.2015.11.002_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.vetpar.2009.12.018","article-title":"Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis","volume":"169","author":"Espino","year":"2010","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.diagmicrobio.2011.03.016","article-title":"Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis","volume":"70","author":"Figueroa-Santiago","year":"2011","journal-title":"Diagn. Microbiol. Inf. Dis."},{"key":"10.1016\/j.exppara.2015.11.002_bib18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcp\/21.7.645","article-title":"The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review","volume":"21","author":"Freund","year":"1951","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.exppara.2015.11.002_bib19","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1016\/j.vaccine.2010.06.039","article-title":"Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1)","volume":"28","author":"Golden","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.exppara.2015.11.002_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2008.10.035","article-title":"The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep","volume":"27","author":"Hacariz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/bst0160101","article-title":"Properties of inclusion bodies from recombinant Escherichia coli","volume":"16","author":"Hartley","year":"1988","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.exppara.2015.11.002_bib23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.intimp.2008.03.005","article-title":"Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment","volume":"8","author":"Hui","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.exppara.2015.11.002_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.vaccine.2011.11.010","article-title":"The non-toxic and biodegradable adjuvant Montanide ISA 720\/CpG can replace Freund's in a cancer vaccine targeting ED-B\u2013a prerequisite for clinical development","volume":"30","author":"Huijbers","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib25","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1517\/13543784.7.9.1475","article-title":"QS-21: a water-soluble triterpene glycoside adjuvant","volume":"7","author":"Kensil","year":"1998","journal-title":"Expert opin. Inv. Drugs"},{"key":"10.1016\/j.exppara.2015.11.002_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.146.2.431","article-title":"Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex","volume":"146","author":"Kensil","year":"1991","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.exppara.2015.11.002_bib27","first-page":"41","article-title":"QS-21 and QS-7: purified saponin adjuvants","volume":"92","author":"Kensil","year":"1998","journal-title":"Dev. Biol. Stand"},{"key":"10.1016\/j.exppara.2015.11.002_bib28","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/j.vaccine.2007.01.057","article-title":"Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1)","volume":"25","author":"Kesik","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib29","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1016\/j.vaccine.2013.09.027","article-title":"Vaccine potential of recombinant saposin-like protein 2 against Fasciolosis gigantica in mice","volume":"31","author":"Kueakhai","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.vetpar.2006.12.017","article-title":"Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD","volume":"145","author":"Lopez-Aban","year":"2007","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib31","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1016\/j.vaccine.2011.09.020","article-title":"The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep","volume":"29","author":"Maggioli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.exppara.2011.09.013","article-title":"A\u00a0recombinant thioredoxin-glutathione reductase from Fasciola hepatica induces a protective response in rabbits","volume":"129","author":"Maggioli","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.imlet.2003.12.001","article-title":"Inclusion bodies from recombinant bacteria as a novel system for delivery of vaccine antigen by the oral route","volume":"91","author":"Malgorzata","year":"2004","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.exppara.2015.11.002_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.vetpar.2004.07.023","article-title":"Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant\/immunomodulator system ADAD","volume":"126","author":"Martinez-Fernandez","year":"2004","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib35","first-page":"340","article-title":"Epidemiology of human fascioliasis: a review and proposed new classification","volume":"77","author":"Mas-Coma","year":"1999","journal-title":"Bull. W. H. O"},{"key":"10.1016\/j.exppara.2015.11.002_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1079\/JOH2005296","article-title":"Epidemiology of fascioliasis in human endemic areas","volume":"79","author":"Mas-Coma","year":"2005","journal-title":"J.\u00a0Helminthol."},{"key":"10.1016\/j.exppara.2015.11.002_bib37","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-3156.1999.00418.x","article-title":"The Northern Bolivian Altiplano: a region highly endemic for human fascioliasis","volume":"4","author":"Mas-Coma","year":"1999","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.exppara.2015.11.002_bib38","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1016\/j.vaccine.2007.01.073","article-title":"Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS-21 adjuvant","volume":"25","author":"Mbawuike","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7007-8-37","article-title":"Immune mechanisms of protection: can adjuvants rise to the challenge?","volume":"8","author":"McKee","year":"2010","journal-title":"BMC Biol."},{"key":"10.1016\/j.exppara.2015.11.002_bib40","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0264-410X(96)00147-8","article-title":"Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase","volume":"14","author":"Morrison","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/rvsc.1998.0270","article-title":"Immune responses of cattle to experimental anti-Fasciola hepatica vaccines","volume":"67","author":"Mulcahy","year":"1999","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.exppara.2015.11.002_bib42","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0264-410X(97)00289-2","article-title":"Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica","volume":"16","author":"Mulcahy","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-3083.2012.02764.x","article-title":"Immunization with Leishmania vaccine-alum-BCG and montanide ISA 720 adjuvants induces low-grade type 2 cytokines and high levels of IgG2 subclass antibodies in the vervet monkey (Chlorocebus aethiops) model","volume":"76","author":"Mutiso","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.exppara.2015.11.002_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-3024.2000.00290.x","article-title":"Fasciola hepatica infection downregulates Th1 responses in mice","volume":"22","author":"O'Neill","year":"2000","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.exppara.2015.11.002_bib45","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1128\/IAI.67.4.1954-1961.1999","article-title":"Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep","volume":"67","author":"Piacenza","year":"1999","journal-title":"Inf. Immunol."},{"key":"10.1016\/j.exppara.2015.11.002_bib46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.exppara.2008.01.014","article-title":"Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice","volume":"119","author":"Preyavichyapugdee","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib47","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0264-410X(96)00289-7","article-title":"Selection of an adjuvant for vaccination with the malaria antigen, MSA-2","volume":"15","author":"Pye","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0166-6851(99)00185-1","article-title":"A\u00a0novel member of the NK-lysin protein family is developmentally regulated and secreted by Fasciola hepatica","volume":"105","author":"Reed","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib49","doi-asserted-by":"crossref","first-page":"e38898","DOI":"10.1371\/journal.pone.0038898","article-title":"Humoral immune responses to a single allele PfAMA1 vaccine in healthy malaria-naive adults","volume":"7","author":"Remarque","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2015.11.002_bib50","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.145.11.3905","article-title":"Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep","volume":"145","author":"Sexton","year":"1990","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.exppara.2015.11.002_bib51","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.4049\/jimmunol.152.4.1861","article-title":"Vaccination of sheep against Fasciola hepatica with glutathione S-transferase. Identification and mapping of antibody epitopes on a three-dimensional model of the antigen","volume":"152","author":"Sexton","year":"1994","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.exppara.2015.11.002_bib52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0304-4017(01)00584-2","article-title":"Early hepatic cytokine mRNA expression in experimental rat fasciolosis","volume":"103","author":"Tliba","year":"2002","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib53","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1016\/S0264-410X(01)00111-6","article-title":"A\u00a0phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers","volume":"19","author":"Toledo","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/expr.1999.4476","article-title":"Fasciola hepatica: an antigen fraction derived from newly excysted juveniles, containing an immunoreactive 32-kDa protein, induces strong protective immunity in rats","volume":"94","author":"van Milligen","year":"2000","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib55","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.vaccine.2007.12.038","article-title":"Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers","volume":"26","author":"Vandepapeliere","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2004.07.009","article-title":"Veterinary parasitic vaccines: pitfalls and future directions","volume":"20","author":"Vercruysse","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00436-013-3650-6","article-title":"Cathepsin L1 mimotopes with adjuvant Quil A induces a Th1\/Th2 immune response and confers significant protection against Fasciola hepatica infection in goats","volume":"113","author":"Villa-Mancera","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2015.11.002_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.vetpar.2007.03.023","article-title":"Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke","volume":"147","author":"Wedrychowicz","year":"2007","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2015.11.002_bib59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-2427(03)00085-0","article-title":"The immune response of rats to vaccination with the cDNA or protein forms of the cysteine proteinase of Fasciola hepatica","volume":"94","author":"Wedrychowicz","year":"2003","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.exppara.2015.11.002_bib60","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1128\/CDLI.12.10.1152-1156.2005","article-title":"Evaluation of immunoglobulin G subclass antibodies against recombinant Fasciola gigantica cathepsin L1 in an enzyme-linked immunosorbent assay for serodiagnosis of human fasciolosis","volume":"12","author":"Wongkham","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.exppara.2015.11.002_bib61","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1016\/j.vaccine.2010.02.054","article-title":"Stability and potency of the Plasmodium falciparum MSP1-19\/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant","volume":"28","author":"Xue","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.11.002_bib62","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2009.04.134","article-title":"The role of CD4 T cell help for CD8 CTL activation","volume":"384","author":"Zhang","year":"2009","journal-title":"Biochem. Biophys. Res. Commu."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489415300606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489415300606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T20:08:09Z","timestamp":1692130089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489415300606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":62,"alternative-id":["S0014489415300606"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2015.11.002","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2015.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}